| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 11/24/2005 | CA2852855A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 11/24/2005 | CA2837792A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 11/24/2005 | CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2816163A1 Methods and kits to detect hereditary angioedema type iii |
| 11/24/2005 | CA2812040A1 Antibodies |
| 11/24/2005 | CA2566716A1 Prolongation of survival of an allograft by inhibiting complement activity |
| 11/24/2005 | CA2566632A1 Polypeptides from non-typeable haemophilus influenzae |
| 11/24/2005 | CA2566588A1 Methods for reducing biofilm formation in infectious bacteria |
| 11/24/2005 | CA2566305A1 Antibodies |
| 11/24/2005 | CA2566257A1 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof |
| 11/24/2005 | CA2565907A1 Methods for diagnosis of acute myeloid leukemia |
| 11/24/2005 | CA2565874A1 Humanized fc.gamma.riib specific antibodies and methods of use thereof |
| 11/24/2005 | CA2565247A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 11/24/2005 | CA2565070A1 Anti-ctgf agents for the treatment of pancreatic cancer |
| 11/24/2005 | CA2565063A1 Glycoprotein vi antibodies and method thereof |
| 11/24/2005 | CA2564126A1 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | CA2563671A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2562024A1 Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 11/23/2005 | EP1598671A1 Diagnosis and therapy of cancer using SGP28-related molecules |
| 11/23/2005 | EP1598419A1 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 11/23/2005 | EP1598369A1 Antibody and use thereof |
| 11/23/2005 | EP1598368A1 Anti-pci neutralizing antibody |
| 11/23/2005 | EP1598363A1 Protein regulating the concentration of calcium in endoplasmic reticulum |
| 11/23/2005 | EP1598362A2 Chlamidya trachomatis antigens |
| 11/23/2005 | EP1597382A2 Genetically modified non-human mammals and cells |
| 11/23/2005 | EP1597378A2 Production of multimeric proteins |
| 11/23/2005 | EP1597372A2 Expression in plants of antibodies against enterotoxigenic escherichia coli |
| 11/23/2005 | EP1597370A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 11/23/2005 | EP1597367A1 Glycorpotein antigen sima135 expressed in metastatic human tumor cells |
| 11/23/2005 | EP1597356A2 Cultured cd14+ antigen presenting cells |
| 11/23/2005 | EP1597352A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 11/23/2005 | EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 11/23/2005 | EP1597283A2 Human antibodies specific for interleukin 15 (il-15) |
| 11/23/2005 | EP1597282A2 ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-1 beta |
| 11/23/2005 | EP1597281A1 Method for reducing levels of c-reactive protein |
| 11/23/2005 | EP1597280A2 Monoclonal antibody production by ebv transformation of b cells |
| 11/23/2005 | EP1597272A2 Lepidoptera voltage-gated calcium channels |
| 11/23/2005 | EP1596885A2 Uses of anti-insulin-like growth factor i receptor antibodies |
| 11/23/2005 | EP1596884A2 Uses of integrin alphavbeta3 antagonists |
| 11/23/2005 | EP1596871A2 T cell regulation |
| 11/23/2005 | EP1596813A2 Lung-expressed polypeptides |
| 11/23/2005 | EP1596811A2 Compositions and methods to modulate immune and inflammatory responses |
| 11/23/2005 | EP1596809A2 Abeta binding molecules |
| 11/23/2005 | EP1596807A2 Immune regulation based on the targeting of early activation molecules |
| 11/23/2005 | EP1596806A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 11/23/2005 | EP1596804A2 SOLUBLE FcyR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 11/23/2005 | EP1546196A4 Marker for cancer |
| 11/23/2005 | EP1381628B1 Inflammation-specific peptides and the uses thereof |
| 11/23/2005 | EP1117767B1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 11/23/2005 | EP0983363B1 Phosphatidyl-3,4.5-triphosphate-dependent protein kinase |
| 11/23/2005 | EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 11/23/2005 | EP0835305B1 Cytokine that induces apoptosis |
| 11/23/2005 | EP0781344B1 Novel implant and novel vector for the treatment of acquired diseases |
| 11/23/2005 | CN1701117A Antibody against enzyme specifically cleaving VON WILLEBRAND factor and assay system using the same |
| 11/23/2005 | CN1699423A Method for preparing antibody C3 against Axin |
| 11/23/2005 | CN1699422A Antibody against cattle piron and method for preparing same |
| 11/23/2005 | CN1699421A Quick preparation process for antibody with high specificity against SARS virus antigen S6-1 |
| 11/23/2005 | CN1698894A Tumor necrosis factor antagonists and their use in endometriosis |
| 11/22/2005 | US6967245 Ucp5 |
| 11/22/2005 | US6967240 proteinaceous compound or functionally active derivative thereof having a binding site for a group of toxins derived from various cyanobacteria, to a method for its production, diagnostic kits, and affinty matrix for use in immunoaffinity column |
| 11/22/2005 | US6967108 use of human monoclonal antibodies in a method for detecting antibodies to IA-2, a method for detecting antibodies to the islet cell antigen IA-2 and a method for detecting the islet cell antigen IA-2 in a sample |
| 11/22/2005 | US6967106 Purification; removal by-products; side effect reduction |
| 11/22/2005 | US6967094 Peptide for use in treatment of cancer, parkinson's and metabolic disorders |
| 11/22/2005 | US6967088 Soluble recombinant botulinum toxin proteins |
| 11/22/2005 | US6967082 Monoclonal antibody |
| 11/22/2005 | US6967029 Method for increasing hematopoietic progenitor cells by stem cell factor |
| 11/22/2005 | CA2174081C Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 11/17/2005 | WO2005108989A2 Assay for antibodies |
| 11/17/2005 | WO2005108988A2 Real time method of detecting acute inflammatory conditions |
| 11/17/2005 | WO2005108985A1 Method of judging systemic arteriosclerosis and judgement reagent |
| 11/17/2005 | WO2005108580A1 Mutant pneumolysin proteins |
| 11/17/2005 | WO2005108575A1 T-type calcium channel splice variant compositions and methods |
| 11/17/2005 | WO2005108432A2 Cd80 (b7-1) binding peptides and uses thereof |
| 11/17/2005 | WO2005108431A1 Methods and compositions for the treatment of ocular neovascularization |
| 11/17/2005 | WO2005108430A2 Monoclonal antibody sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent |
| 11/17/2005 | WO2005108428A2 Cd40 splice variants and their uses |
| 11/17/2005 | WO2005108427A2 Method for producing soluble mhc proteins |
| 11/17/2005 | WO2005108420A1 Cancer associated antigens |
| 11/17/2005 | WO2005107803A2 Methods of determining the prognosis and treatment of subjects with lung cancer |
| 11/17/2005 | WO2005107802A2 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 11/17/2005 | WO2005107801A2 Systems and methods for treating human inflammatory and proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors and/or ucp and/or fas antibodies |
| 11/17/2005 | WO2005107800A1 Monoclonal antibodies to hepatocyte growth factor |
| 11/17/2005 | WO2005107799A1 REMEDY FOR CANCER CONTAINING ANTI-Necl-5 ANTIBODY AS THE ACTIVE INGREDIENT |
| 11/17/2005 | WO2005107784A1 Remedy for thrombopenia |
| 11/17/2005 | WO2005082937A3 A method of providing a purified, virus safe antibody preparation |
| 11/17/2005 | WO2005058251A3 Hla-dr-specific antibodies, compositions and methods |
| 11/17/2005 | WO2005049802A3 Anti-hydroxylase antibodies and uses thereof |
| 11/17/2005 | WO2005047309A3 Prophylactic and therapeutic monoclonal antibodies |
| 11/17/2005 | WO2004087041A3 An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same |
| 11/17/2005 | WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 11/17/2005 | WO2004035747A3 Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors |
| 11/17/2005 | WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 11/17/2005 | US20050256299 Vaccines |
| 11/17/2005 | US20050256049 Chimeric toxins for targeted therapy |
| 11/17/2005 | US20050256033 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 11/17/2005 | US20050255591 Transplanting human hepatocytes into a liver of an immunodeficient hepatopathy mouse, feeding the mouse transplanted under such a condition as being protected from the attack by human complement produced by the human hepatocytes thereby proliferating the transplanted human hepatocytes in the mouse liver |
| 11/17/2005 | US20050255560 Ztnf11, a tumor necrosis factor |
| 11/17/2005 | US20050255559 Isolated nucleic acid molecule(s) encoding a human calcium sensitive potassium channel subunit protein designated beta2, encoded proteins, and uses thereof |
| 11/17/2005 | US20050255552 Antibody specificity transfer using minimal essential binding determinants |
| 11/17/2005 | US20050255550 Suppression of xenotransplant rejection |